Michele Masetti

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Elio Jovine · 8 shared papers, 2012–2022 · strength 0.54
   • Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
   • Paper The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer. DOI 10.1016/j.hbpd.2019.06.004↗
   • Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
2. Sirio Fiorino · 6 shared papers, 2012–2022 · strength 0.39
   • Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
   • Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
   • Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
3. Dario de Biase · 4 shared papers, 2018–2022 · strength 0.33
   • Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
   • Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
   • Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
4. Giovanni Tallini · 3 shared papers, 2018–2022 · strength 0.28
   • Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
   • Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
   • Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
5. Michela Visani · 3 shared papers, 2018–2020 · strength 0.21
   • Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
   • Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
   • Paper Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. DOI 10.1016/j.pan.2017.11.001↗
6. Carlo Fabbri · 3 shared papers, 2018–2020 · strength 0.21
   • Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
   • Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
   • Paper Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. DOI 10.1016/j.pan.2017.11.001↗
7. Deborah Malvi · 1 shared paper, 2022 · strength 0.12
   • Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
8. Mariacristina Di Marco · 1 shared paper, 2022 · strength 0.12
   • Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
9. Alessandro Cucchetti · 1 shared paper, 2019 · strength 0.09
   • Paper The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer. DOI 10.1016/j.hbpd.2019.06.004↗
10. Matteo Serenari · 1 shared paper, 2019 · strength 0.09
    • Paper The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer. DOI 10.1016/j.hbpd.2019.06.004↗
11. Giorgio Ercolani · 1 shared paper, 2019 · strength 0.09
    • Paper The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer. DOI 10.1016/j.hbpd.2019.06.004↗
12. Nicola Zanini · 2 shared papers, 2013–2015 · strength 0.09
    • Paper Surgery for isolated liver metastases from pancreatic cancer. DOI 10.1007/s13304-015-0283-6↗
    • Paper Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a sys… DOI 10.1016/j.pan.2013.01.005↗
13. Chiara Birtolo · 1 shared paper, 2018 · strength 0.05
    • Paper Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. DOI 10.1016/j.pan.2017.11.001↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.